Ellipsis Health is a San Francisco, CA–based AI healthcare technology company that developed Sage, an emotionally intelligent AI voice agent for care management and behavioral health monitoring. Sage is powered by the company’s patented Empathy Engine and is designed to expand provider capacity, streamline workflows, and elevate patient engagement. The company serves leading healthcare providers and payers, focusing on patients with complex physical, behavioral, and social needs that drive the majority of healthcare costs. Ellipsis plans to use new funding to accelerate Sage adoption across healthcare providers, payers, and care management organizations, enhance its AI capabilities, and deepen integration with clinical systems. The company was founded and is led by CEO Mainul Mondal. Financially, Ellipsis has secured a $45M Series A to support these product and go-to-market initiatives. Ellipsis Health, based in San Francisco, develops an AI-powered speech-based vital sign to quantify and manage stress, depression, and anxiety at scale. Its integrated behavioral health solution uses machine-learning algorithms and cloud-based deep learning models to assess patient speech and generate automated assessments for clinical decision support. The company helps healthcare providers and payers identify and stratify patient populations. Ellipsis intends to use the new funding to grow its customer base, expand global partnerships, build a multidisciplinary team, and continue research and development of voice-based technology. It also plans to expand its voice vital sign to address the mental health of children and adolescents. Financially, the company raised a $26M Series A that brought total funding to $31M.

Total raised

$71M

Funding rounds

2

Latest round

Series A

Latest activity

Jun 2025